Supercharge Your Innovation With Domain-Expert AI Agents!

Compounds for modulating TRPV3 function

A compound and functional technology, applied in the field of RPV, antagonizing TRPV3 function, calcium permeation non-selective cation channel, inward current field, can solve problems such as increased intracellular calcium level or concentration

Inactive Publication Date: 2008-07-30
HYDRA BIOSCIENCES LLC
View PDF15 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Normally, voltage-gated calcium channels respond to membrane depolarization and open to allow calcium influx from the extracellular medium, resulting in increased intracellular calcium levels or concentrations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds for modulating TRPV3 function
  • Compounds for modulating TRPV3 function
  • Compounds for modulating TRPV3 function

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0647] Embodiment 1. Synthesis of compounds of the present invention

[0648] Synthesis of 2-chloro-1-(8-methyl-3,4-dihydro-2H-quinolin-1-yl)ethanone (2):

[0649]

[0650] 2-Chloro-1-(8-methyl-3,4-dihydro-2H-quinolin-1-yl)ethanone (2): to 8-methyl-1,2,3,4-tetrahydro Anhydrous CH of quinoline (1) (2.77 g, 18.8 mmol) 2 Cl 2 (50mL), chloroacetyl chloride (1.80mL, 22.6mmol) was added at 0°C, followed by dropwise addition of Et 3 N (6.30 mL, 45.2 mmol). will react at N 2 Stir overnight. Then the reaction mixture was washed with CH 2 Cl 2 (50 mL), washed with water (2 x 15 mL), and saturated NaCl (15 mL). via MgSO 4 Drying, filtration, and concentration gave compound 2 (3.7 g). This crude material was used in subsequent reactions without further purification.

[0651] Synthesis of 2-chloro-1-(3,4-dihydro-2H-quinolin-1-yl)ethanone (4):

[0652]

[0653] 2-Chloro-1-(3,4-dihydro-2H-quinolin-1-yl)ethanone (4): to 1,2,3,4-tetrahydroquinoline (3, 2.00g, 15.0mmol ) of...

Embodiment 2

[0808] Example 2. High throughput screening analysis

[0809] This assay relies on the detection of intracellular calcium concentrations ([Ca 2+ ] i ) rises after channel activation. Ca 2+ Rising utilization is loaded into cells and subsequently directed to the [Ca 2+ ] i Fluorescent Ca 2+ indicator for quantification. Ca 2+ Influx follows activation of TRPV3 channels. Inhibit the [Ca 2+ ] i Rising compounds were viewed as targets for further research.

[0810] A commercially available HEK293 / TREx line (Invitrogen) was stably transfected with the TRPV3 construct and screened by immunostaining for clones with TRPV3 expression after stimulation with 1 μg / ml tetracycline. Clonal TRPV3-expressing cells were maintained in growth medium recommended by the manufacturer supplemented with 100 μg / ml hygromycin to facilitate maintenance of the TRPV3 construct. After growing to near-confluent sheets, cells were plated in 384-well plates at a density of ~25,000 cells / well in ...

Embodiment 3

[0811] Embodiment 3. Diaphragm clamp experiment

[0812] Whole-cell patch-clamp experiments allow detection of currents through TRPV3 channels in the above cell lines. A glass electrode is brought into contact with a single cell, and the cell membrane is then disrupted, allowing the voltage across the cell membrane to be controlled and the current flowing through the membrane to be measured using an amplifier connected to the electrode. The perfusion system allows control of the extracellular solution, including the addition of current blockers and activators. The current can be activated by heating the solution to 28°C or hotter, or by adding 20 μM 2-APB to the solution.

[0813] TRPV3 cells were induced for 20-48 hours, removed from growth plates, and replated on coverslips at low density (to obtain good physical separation of single cells) for measurements. In some instances, cells were grown overnight on coverslips at low density. Patch-clamp recordings were performed...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

Description

Background technique [0001] A variety of different ion channel proteins exist to mediate the flow of ions across cell membranes. Proper expression and function of ion channel proteins are critical for maintaining cellular functions, intracellular communication, and the like. A large number of diseases are the result of misregulation of membrane potential or abnormal calcium regulation. Given the importance of ion channels in regulating membrane potential and ion flux in cells, the identification of agents that can promote or inhibit specific ion channels is of great interest as research tools and possible therapeutic agents. [0002] One such channel is the Transient Receptor Potential V3 (TRPV3) channel. TRPV3 is a calcium permeable channel, specifically a calcium permeable non-selective cation channel. In addition to calcium ions, TRPV3 channels are also permeable to other cations, such as sodium. Thus, TRPV3 channels regulate membrane potential by regulating the flux of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D417/12C07D401/12C07D513/04C07D409/12A61K31/428A61K31/429A61P29/00
CPCC07D495/04C07D409/04A61K31/506C07D215/54A61K31/4709A61P1/02A61P1/04A61P1/16A61P11/00A61P11/06A61P11/14A61P13/10A61P13/12A61P17/00A61P17/02A61P17/04A61P17/06A61P17/14A61P19/02A61P21/04A61P25/00A61P25/02A61P25/06A61P25/14A61P25/16A61P25/28A61P29/00A61P29/02A61P3/00A61P3/04A61P3/14A61P35/00A61P37/02A61P43/00A61P9/14A61P3/10A61K9/0014A61K9/0053A61K31/427A61K31/47A61K31/498A61K31/538A61K31/55
Inventor 介弘·A·崇克里斯托弗·范格马格达雷那·M·莫兰丹尼斯·约翰·昂德伍德甄晓广艾米·里普卡曼弗雷德·魏格勒小威廉·C·卢马格伦·R·拉森
Owner HYDRA BIOSCIENCES LLC
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More